As a partner at Ernst & Young LLP, Benjamin leads commercial strategy projects for pharmaceutical and biotech clients, leveraging his PhD in Medical Engineering and Physics and his extensive industry experience. He has successfully delivered solutions for complex challenges across diverse therapeutic areas and approaches.
Benjamin’s mission is to help clients optimize their product development and launch strategies by applying his deep knowledge of cell biology, biochemistry and engineering as well as his robust business acumen and analytical skills. He has a passion for innovation and excellence and enjoys collaborating with multidisciplinary teams and stakeholders to achieve impactful outcomes. Some of his recent achievements include securing a large contract with a leading oncology company, developing a novel vaccine market assessment framework and contributing to a publication on radiotherapy trends and opportunities.
How Benjamin is shaping the future with confidence
"I strive to continuously confirm that our people are properly trained and equipped to navigate the ever-changing business landscape. I leverage a deep background in engineering and biomedicine, including diverse therapeutic areas such as oncology and cardiovascular disease, along with robust business experience in the pharma industry to help position organizations for excellence."